Abstract
Amlodipine-induced gingival overgrowth (AIGO) is characterized by an increase in the volume of connective tissue matrix in the gingiva. Amlodipine is one of the commonly prescribed antihypertensive drugs, and gingival hyperplasia is one overlooked side effect in patients taking amlodipine. Many factors can contribute to the development of gingival overgrowth, including: plaque control; periodontal variables; medications and their relative dose; age; sex; and, genetic factors. Currently, more than 20 prescription medications are associated with gingival enlargement. Drugs associated with gingival overgrowth can be broadly divided into three categories: Anticonvulsants, calcium channel blockers, and immunosuppressant. In the present case, a 66 year old male patient who presented with gingival overgrowth and was found taking Amlodipine for 20 year.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
